Treatment of hepatocellular carcinoma: pathologic results after chemoembolization and liver transplantation

Transplant Proc. 1999 Feb-Mar;31(1-2):416-7. doi: 10.1016/s0041-1345(98)01686-8.

Authors

D Roumilhac¹, G Sergent, F R Pruvot, N Talbodec, L Gamblez, O Ernst, J C Paris, C L'herminé, M Lecomte-Houcke

Affiliation

¹ Service de Chirurgie Générale et Transplantation, Hôpital A. Calmette, Lille (F).

PMID: 10083168
DOI: 10.1016/s0041-1345(98)01686-8

No abstract available

MeSH terms

Adult
Antineoplastic Agents / administration & dosage
Carcinoma, Hepatocellular / mortality
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / surgery
Carcinoma, Hepatocellular / therapy*
Chemoembolization, Therapeutic*
Contraindications
Doxorubicin / administration & dosage
Female
Follow-Up Studies
Humans
Liver Neoplasms / mortality
Liver Neoplasms / pathology
Liver Neoplasms / surgery
Liver Neoplasms / therapy*
Liver Transplantation* / mortality
Liver Transplantation* / pathology
Male
Middle Aged
Retrospective Studies
Survival Rate
Time Factors
Waiting Lists

Substances

Antineoplastic Agents
Doxorubicin